Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Published:2023-04-26 Issue:5 Volume:46 Page:e117-e117
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Goldenberg Ronald M.¹^ORCID,Jain Akshay B.²^ORCID

Affiliation:

1. 1LMC Diabetes & Endocrinology, Concord, Ontario, Canada

2. 2TLC Diabetes and Endocrinology, Surrey, British Columbia, Canada

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/46/5/e117/702231/dc222300.pdf

Reference5 articles.

1. GLP-1 receptor agonists and the risk of thyroid cancer;Bezin;Diabetes Care,2023

2. Tumor volume doubling time in active surveillance of papillary thyroid carcinoma;Oh;Thyroid,2019

3. Considerations for pharmacoepidemiological studies of drug-cancer associations;Pottegård;Basic Clin Pharmacol Toxicol,2018

4. American Cancer Society . Cancer facts and figures, 2022. Accessed 25 November 2022. Available from https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html

5. Use of GLP-1 receptor agonists and occurrence of thyroid disorders: a meta-analysis of randomized controlled trials;Hu;Front Endocrinol,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging In Vitro and In Vivo Models: Hope for the Better Understanding of Cancer Progression and Treatment;Advanced Biology;2024-04-05

2. Disadvantages of the obesity blockbuster illuminated;Die Diabetologie;2023-10-11

3. Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390;Diabetes Care;2023-04-26